Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
Clinical trial NCT01765361 · COMPLETED
Trial details
- NCT number
- NCT01765361
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-09-01
- Primary completion
- 2015-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.